Fort Lauderdale, FL · Founded 2022 · Privately Held (backing)
Developer of epigenetic biomarkers intended to promote proactive pet healthcare. EpiPaws is based in Fort Lauderdale, FL and was founded in 2022. Its last reported valuation was $1.3 million in Dec 2024. It has raised $420,000.
Last reported valuation
$1.3M
Oct 2026
Priced at
—
Total raised
$420K
Last round
—
Cap table — not yet on record
EpiPaws's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Private Market View
More of EpiPaws with a free Private Market View account
·Watch EpiPaws: the Monday email on marks, rounds and moves
